Detalhe da pesquisa
1.
A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus (HSV) Type 2 Vaccine, HSV529, in Adults With or Without HSV Infection.
J Infect Dis
; 220(6): 990-1000, 2019 08 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31058977
2.
Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial.
Lancet
; 384(9959): 2046-52, 2014 Dec 06.
Artigo
Inglês
| MEDLINE | ID: mdl-25132507
3.
Blockade of peanut allergy with a novel Ara h 2-Fcγ fusion protein in mice.
J Allergy Clin Immunol
; 131(1): 213-21.e1-5, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23199607
4.
Superior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults ≥ 60 years of age: Results from a phase III, randomized clinical trial.
Vaccine
; 41(15): 2553-2561, 2023 04 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36906404
5.
Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6â¯months throughâ¯<18â¯years of age: A randomized controlled phase II dose-finding trial.
Vaccine
; 39(11): 1572-1582, 2021 03 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33610374
6.
Introductory paper: High-dose influenza vaccine.
Vaccine
; 39 Suppl 1: A1-A5, 2021 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33549389
7.
A Phase II, randomized, immunogenicity and safety study of a quadrivalent meningococcal conjugate vaccine, MenACYW-TT, in healthy adolescents in the United States.
Vaccine
; 38(19): 3560-3569, 2020 04 23.
Artigo
Inglês
| MEDLINE | ID: mdl-32209248
8.
Immunogenicity and safety of high-dose quadrivalent influenza vaccine in Japanese adults ≥65 years of age: a randomized controlled clinical trial.
Hum Vaccin Immunother
; 16(4): 858-866, 2020 04 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31634025
9.
Safety and immunogenicity of high-dose quadrivalent influenza vaccine in adults ≥65â¯years of age: A phase 3 randomized clinical trial.
Vaccine
; 37(39): 5825-5834, 2019 09 16.
Artigo
Inglês
| MEDLINE | ID: mdl-31431411
10.
Protection against malaria at 1 year and immune correlates following PfSPZ vaccination.
Nat Med
; 22(6): 614-23, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27158907
11.
Safety and immunogenicity of a trivalent recombinant PcpA, PhtD, and PlyD1 pneumococcal protein vaccine in adults, toddlers, and infants: A phase I randomized controlled study.
Vaccine
; 33(36): 4610-7, 2015 Aug 26.
Artigo
Inglês
| MEDLINE | ID: mdl-26143615
12.
Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine.
Science
; 341(6152): 1359-65, 2013 Sep 20.
Artigo
Inglês
| MEDLINE | ID: mdl-23929949
13.
Corrigendum: Protection against malaria at 1 year and immune correlates following PfSPZ vaccination.
Nat Med
; 22(6): 692, 2016 06 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27270781
14.
The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification.
J Pharm Biomed Anal
; 51(5): 1069-77, 2010 Apr 06.
Artigo
Inglês
| MEDLINE | ID: mdl-20036089